Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Samsung Biologics
35 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Down Stream Processing
Expediting Biologics Drug Development: Downstream Strategies to Accelerate Preclinical Development Timelines
PAO-04-24-CL-05
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
PAO-03-24-CL-03
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
PAO-03-24-CL-02
Bispecific Antibodies
Accelerating the Development and Production of High-Quality Bispecific Antibodies
PAO-03-24-CL-01
Drug Development
Podcast: Insights from CDO Experts from Samsung Biologics
POD-01-24-CL-01
Roundtable
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
PAO-12-23-RT-02
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
PAO-12-23-RT-01
Glycosylation
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
PAO-12-23-CL-06
Supply Chain
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
PTV-12-23-CL-02
Antibody-Drug Conjugates
Reducing ADC Development Timelines with Integrated Development and Manufacturing Services
PAO-11-23-CL-01
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
PR-M10-23-06
Aseptic Fill/Finish
Webinar: Capitalizing on CDMO Expertise in Aseptic Fill/Finish, Presented by Samsung Biologics
PAO-08-23-PATV-02
CDMO Partnerships
Webinar: A Developer's Guide to Partnering With the Right CDMO, Presented by Samsung Biologics
PAO-08-23-PATV-01
Roundtable: Artificial Intelligence
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
PAO-07-23-RT-01
Roundtable: Patient Centricity
How is an increased focus on patient-centric concerns influencing the way that you work?
PAO-07-23-RT-02
CDMO Partnerships
Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market
PAO-05-23-CL-07
New Biomanufacturing Facility
Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion
PR-M03-23-05
mRNA Ultra-Cold Chain Management
Ultra-Cold Chain and Supply Chain Management Strategies for mRNA
PAO-02-23-CL-09
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
PAO-01-23-RT-01
mRNA Manufacturing
Investing in the Future of mRNA Manufacturing
PAO-11-022-CL-02
Financial Results
Samsung Biologics Reports First Quarter 2022 Financial Results
PR-M04-22-14
Leadership
Q: What’s the key to being a leader in the industry?
PAO-03-022-RT-02
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
PAO-03-022-RT-01
M&A
Samsung Biologics Reaches Agreement With Biogen to Acquire Full Ownership of Samsung Bioepis
PR-M01-22-21
1
2
»